A pan-coronavirus peptide inhibitor prevents SARS-CoV-2 infection in mice by intranasal delivery
Lili Wu(Chinese Academy of Sciences), George F. Gao(Chinese Academy of Sciences), Hang Yang(Wuhan Institute of Virology), Yan Chai(Chinese Academy of Sciences), Lin Cheng(University of Electronic Science and Technology of China), Yu Hu(University of Science and Technology of China), Wenwen Lei(China Pharmaceutical University), Guizhen Wu(Chinese Center For Disease Control and Prevention), Anqi Zheng(Peking University), Qihui Wang(Shanxi Agricultural University), William Jun Liu(National Institute for Viral Disease Control and Prevention), Jing Qu(Biomarker Technologies (China)), Jiantao Chen(First Affiliated Hospital of Guangzhou Medical University), Shaogui Zeng, Yangming Tang
Cited by 26
Related Papers
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
|Trends in Microbiology|2016|3.1k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k